A Single Centre, Open Label, One Sequence, Cross-over Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics of Single Inhaled Doses of Nemiralisib in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 04 Jun 2019
Price : $35 *
At a glance
- Drugs Nemiralisib (Primary) ; Itraconazole
- Indications Asthma; Bronchiectasis; Chronic obstructive pulmonary disease; Immunodeficiency disorders
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline
- 31 Aug 2018 Biomarkers information updated
- 08 Mar 2018 Status changed from active, no longer recruiting to completed.
- 08 Feb 2018 Status changed from recruiting to active, no longer recruiting.